MET and neoplasm: Following a single IV injection of 124I-labeled or 111In-DTPA labeled MET-ADCs, the tumor and two major highly vascularized MET expressing organs/tissue (liver and kidney) concentrations were measured for each molecule over the course of 168 hours post administration using quantitative non-invasive SPECT/CT imaging (Fig 7).